47.11
price down icon0.21%   -0.10
after-market 시간 외 거래: 46.77 -0.34 -0.72%
loading
전일 마감가:
$47.21
열려 있는:
$47.13
하루 거래량:
312.22K
Relative Volume:
0.50
시가총액:
$855.11M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-336.50
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
-7.55%
1개월 성능:
+66.00%
6개월 성능:
+129.36%
1년 성능:
+77.84%
1일 변동 폭
Value
$46.76
$48.50
1주일 범위
Value
$43.81
$52.24
52주 변동 폭
Value
$14.63
$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
명칭
Rigel Pharmaceuticals
Name
전화
650-624-1100
Name
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
직원
164
Name
트위터
@rigelpharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
RIGL's Discussions on Twitter

RIGL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RIGL
Rigel Pharmaceuticals
47.11 856.92M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.26 117.50B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
722.83 76.06B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.56 62.53B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
916.31 56.75B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
205.04 44.10B 447.02M -1.18B -906.14M -6.1812

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-11-05 업그레이드 Jefferies Hold → Buy
2023-04-03 재개 Piper Sandler Neutral
2022-06-09 다운그레이드 Citigroup Buy → Neutral
2022-06-08 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2022-06-08 다운그레이드 Piper Sandler Overweight → Neutral
2022-03-23 개시 B. Riley Securities Neutral
2020-11-09 다운그레이드 JP Morgan Overweight → Neutral
2019-11-15 재개 Cantor Fitzgerald Overweight
2019-09-26 재개 JP Morgan Overweight
2019-03-01 재확인 Cantor Fitzgerald Overweight
2018-08-27 개시 Citigroup Buy
2018-05-02 재확인 Cantor Fitzgerald Overweight
2017-12-21 재개 Piper Jaffray Overweight
2017-12-15 개시 Cantor Fitzgerald Overweight
2017-11-06 재개 H.C. Wainwright Buy
2017-03-09 재확인 H.C. Wainwright Buy
2016-08-31 재확인 H.C. Wainwright Buy
2016-08-30 재확인 Piper Jaffray Overweight
2016-07-13 개시 H.C. Wainwright Buy
2016-06-13 개시 Piper Jaffray Overweight
2016-04-22 업그레이드 JP Morgan Neutral → Overweight
2013-04-08 재확인 Stifel Buy
2012-11-29 개시 UBS Neutral
2012-11-06 재확인 Oppenheimer Outperform
2012-03-26 개시 Canaccord Genuity Hold
2010-12-10 다운그레이드 MP Advisors Outperform → Market Perform
모두보기

Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스

pulisher
01:51 AM

Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser

01:51 AM
pulisher
01:43 AM

Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser

01:43 AM
pulisher
04:40 AM

Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser

04:40 AM
pulisher
Dec 03, 2025

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025 - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

What analysts say about Rigel Pharmaceuticals Inc RI2 stockVolume Analysis Techniques & Accelerated Financial Growth - earlytimes.in

Nov 30, 2025
pulisher
Nov 28, 2025

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Nov 28, 2025
pulisher
Nov 28, 2025

Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Nov 28, 2025
pulisher
Nov 28, 2025

Rigel Pharmaceuticals Inc RI2 Stock Analysis and ForecastSmall Cap Stock Opportunities & Discover Your Financial Freedom Formula - earlytimes.in

Nov 28, 2025
pulisher
Nov 27, 2025

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Nov 27, 2025
pulisher
Nov 26, 2025

Rigel Pharmaceuticals (RIGL) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat

Nov 26, 2025
pulisher
Nov 26, 2025

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Nov 26, 2025
pulisher
Nov 26, 2025

Rigel Pharmaceuticals (Nasdaq: RIGL) plans Dec. 3 talk at Piper Sandler conference - Stock Titan

Nov 26, 2025
pulisher
Nov 25, 2025

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Nov 25, 2025
pulisher
Nov 23, 2025

Institutional Investors Control 85% of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and Were Rewarded Last Week After Stock Increased 10% - 富途牛牛

Nov 23, 2025
pulisher
Nov 23, 2025

Rigel Stock Surges on Upward Earnings Revisions - Ad-hoc-news.de

Nov 23, 2025
pulisher
Nov 23, 2025

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 54% - 富途牛牛

Nov 23, 2025
pulisher
Nov 22, 2025

How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals - Yahoo Finance

Nov 22, 2025
pulisher
Nov 21, 2025

Rigel Pharmaceuticals, Inc.Common Stock (Nasdaq:RIGL) Stock Quote - Markets Financial Content

Nov 21, 2025
pulisher
Nov 21, 2025

RIGLRigel Pharmaceuticals Stock Price and Quote - Finviz

Nov 21, 2025
pulisher
Nov 21, 2025

How Rigel Pharmaceuticals Inc. (RI2) stock stacks up against competitorsJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Rigel Pharmaceuticals Inc. (RI2) stock benefits from digital adoptionOptions Play & Daily Profit Focused Stock Screening - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

How Rigel Pharmaceuticals Inc. (RI2) stock trades in high volatilityTrade Entry Summary & Breakout Confirmation Trade Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Rigel Pharmaceuticals Inc. stock reach Wall Street targets2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What insider trading reveals about Rigel Pharmaceuticals Inc. stock2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Measuring Rigel Pharmaceuticals Inc.’s beta against major indices2025 Performance Recap & Verified Trade Idea Suggestions - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can machine learning forecast Rigel Pharmaceuticals Inc. recoveryJuly 2025 Summary & Weekly Stock Performance Updates - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock sustain dividend payoutsEarnings Risk Report & Precise Trade Entry Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Rigel Pharmaceuticals Inc. (RI2) stock benefits from AI revolutionWeekly Market Report & Fast Moving Stock Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applying big data sentiment scoring on Rigel Pharmaceuticals Inc.2025 Growth vs Value & Weekly Market Pulse Updates - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value estimate for Rigel Pharmaceuticals Inc. (RI2) stock in 2025Portfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Rigel Pharmaceuticals Inc. stock remains undervaluedJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidity2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Rigel Pharmaceuticals Inc. stock attract ESG investorsPortfolio Risk Report & Intraday High Probability Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025

Rigel Pharmaceuticals (RIGL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Rigel Pharmaceuticals 주식 (RIGL) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Schorno Dean L
EVP & Chief Financial Officer
Feb 05 '25
Sale
21.93
1,734
38,020
57,235
Santos David A
EVP, Chief Commercial Officer
Feb 04 '25
Sale
20.92
2,125
44,457
53,500
Santos David A
EVP, Chief Commercial Officer
Feb 05 '25
Sale
21.93
1,796
39,379
51,704
RODRIGUEZ RAUL R
CEO, President
Feb 04 '25
Sale
20.92
4,952
103,601
243,854
RODRIGUEZ RAUL R
CEO, President
Feb 05 '25
Sale
21.93
4,400
96,474
239,454
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 04 '25
Sale
20.92
1,448
30,294
40,169
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 05 '25
Sale
21.93
1,339
29,359
38,830
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
자본화:     |  볼륨(24시간):